---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281925088.md"
description: "Oruka Therapeutics shares are trading higher after Barclays maintained its Overweight rating and raised its price target on the stock from $50 to $78."
datetime: "2026-04-07T18:48:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281925088.md)
  - [en](https://longbridge.com/en/news/281925088.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281925088.md)
---

# 

Oruka Therapeutics shares are trading higher after Barclays maintained its Overweight rating and raised its price target on the stock from $50 to $78.

### Related Stocks

- [ORKA.US](https://longbridge.com/en/quote/ORKA.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)

## Related News & Research

- [BUZZ-Oruka Therapeutics rises after upsized $700 mln stock offering](https://longbridge.com/en/news/284555655.md)
- [Oruka Therapeutics Commences Public Offering Of $500 Mln Of Shares And Warrants](https://longbridge.com/en/news/284342940.md)
- [AbbVie beats Q1 revenue, profit estimates on Skyrizi, Rinvoq demand; lifts profit outlook](https://longbridge.com/en/news/284564851.md)
- [Oruka Therapeutics Prices Upsized $700 Mln Offering To Advance Psoriasis Pipeline](https://longbridge.com/en/news/284478592.md)
- [Oruka Therapeutics To Unveil 16 Week Data From EVERLAST-A Trial For ORKA-001 In Plaque Psoriasis](https://longbridge.com/en/news/284172892.md)